BELLEVUE, Wash.--(BUSINESS WIRE)--Confirma®, pioneer and leader in application-specific CAD for MRI, announced today that it has installed CADstream® for prostate at research sites including MRI at Belfair, Beth Israel, Simonmed and Lahey Clinic. These research sites are assisting Confirma in the development and commercialization of CADstream for prostate. The prostate application will offer physicians comprehensive and clinically valuable tools for improved quality, standardization and efficiency in MRI studies of the prostate. The Company recently exhibited at the National Conference on Prostate Cancer in Los Angeles and the AdMeTech Foundation Conference in Washington, DC with its research version of CADstream for prostate.
